XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Inventories
 9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Inventories Inventories
The Company purchases intravenous chemotherapy drugs and oral prescription drugs from various suppliers. See Note 2 for a summary of the Company’s policies relating to intravenous chemotherapy and oral prescription drugs inventory.
The Company’s inventories as of September 30, 2023 and December 31, 2022 were as follows:
(in thousands)September 30, 2023December 31, 2022
Oral drug inventory$2,924 $2,130 
IV drug inventory9,250 7,131 
Total$12,174 9,261